Elevated homocysteine levels in patients with slow coronary flow: Relationship with Helicobacter pylori infection

Helicobacter

Volumn 12, Issue 4, 2007, Pages 298-305

  Evrengul, Harun ^a,c   Tanriverdi, Halil ^a   Kuru, Omur ^a   Enli, Yasar ^a   Yuksel, Dogangun ^a   Kilic, Ayhan ^b   Kaftan, Asuman ^a   Kirac, Suna ^a   Kilic, Mustafa ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Helicobacter pylori; Homocysteine; Slow coronary flow

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; FOLIC ACID BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE REGRESSION; PRIORITY JOURNAL; SLOW CORONARY FLOW; STATISTICAL SIGNIFICANCE; THROMBOLYSIS IN MYOCARDIAL INFARCTION METHOD; UREA BREATH TEST; VITAMIN BLOOD LEVEL;

ADULT; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; CORONARY CIRCULATION; FEMALE; FOLIC ACID; HELICOBACTER INFECTIONS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN B 12;

HELICOBACTER PYLORI;

EID: 34547600481     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00505.x     Document Type: Article

References (49)

1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries, a new angiographic finding. Am Heart J 1972 84 : 66 71.
2. Sezgin AT, Sigirci A, Barutcu I, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003 14 : 155 61.
3. Erbay AR, Turhan H, Yasar AS, Ayaz S, Sahin O, Senen K, Sasmaz H, Yetkin E. Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol 2005 102 : 419 23.
4. Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R. Elevated plasma homocysteine level in slow coronary flow. Int J Cardiol 2005 101 : 143 5.
5. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, Sanderson JE, Metreweli C, Celermajer DS. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997 96 : 2542 4.
6. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997 277 : 1775 81.
7. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997 95 : 1119 21.
8. Pekdemir H, Cin VG, Cicek D, Camsari A, Akkus N, Doven O, Parmaksiz HT. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004 59 : 127 33.
9. Vrints C, Herman AG. Role of the endothelium in the regulation of coronary artery tone. Acta Cardiol 1991 46 : 399 418.
10. Blaser MJ. Helicobacter pylori: its role in disease. Clin Infect Dis 1992 15 : 386 91.
11. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994 71 : 437 9.
12. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori, and Chlamydia pneumoniae infections with coronary heart disease, and cardiovascular risk factors. Br Med J 1995 311 : 711 4.
13. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996 75 : 568 72.
14. Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon AT, Grant PJ. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997 35 : 120 4.
15. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent Helicobacter pylori strains with ishemic heart disease. Circulation 1998 97 : 1675 9.
16. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, Marz W, Pepys MB, Brenner H. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999 100 : 2326 31.
17. Quinn MJ, Foley JB, Mulvihill NT, Lee J, Crean PA, Walsh MJ, O'Morain CA. Helicobacter pylori serology in patients with angiographically documented coronary artery disease. Am J Cardiol 1999 83 : 1664 6, A6.
18. Brenner H, Berg G, Frohlich M, Boeing H, Koenig W. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population based study. Atherosclerosis 1999 147 : 399 403.
19. Murray LJ, Bamford KB, Kee F, McMaster D, Cambien F, Dallongeville J, Evans A. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction. Atherosclerosis 2000 149 : 379 85.
20. Sung JJ, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart 1996 76 : 305 7.
21. Markle HV. Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status. Med Hypotheses 1997 49 : 289 92.
22. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation, 1996 93 : 879 88.
23. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, Dell'Italia LJ, Scibilia G, Motta P, Campa PP. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996 37 : 375 81.
24. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina and patent large coronary arteries. Circulation 1986 74 : 964 72.
25. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001 87 : 777 9.
26. Camsari A, Pekdemir H, Cicek D, Polat G, Akkus MN, Döven O, Cin G, Katircibasi T, Parmaksiz T. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003 67 : 1022 8.
27. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocystein(e)mia. J Clin Invest 1996 98 : 24 9.
28. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997 337 : 230 6.
29. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols: superoxide-dependent and - independent mechanisms. J Lipid Res 1993 34 : 2051 61.
30. Loscalzo J. The oxidation stress of hyperhomcyst(e)inemia. J Clin Invest 1996 98 : 5 7.
31. Stanger O, Semmelrock HJ, Wonisch W, Bos U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 2002 303 : 158 62.
32. Willems FF, Aengevaeren WR, Boers GH, Blom HJ, Verheugt FW. Coronary endothelial function in hyperhomocysteinemia: improve-ment after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coll Cardiol 2002 40 : 766 72.
33. Zito F, Di Castelnuovo A, D'Orazio A, et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999 82 : 14 8.
34. Pieniazek P, Karczewska E, Duda A, Tracz W, Pasowicz M, Konturek SJ. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 1999 50 : 743 51.
35. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999 142 : 207 10.
36. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S. Does Eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 2005 50 : 1228 31.
37. Ozer B, Serin E, Gumurdulu Y, Kayaselcuk F, Anarat R, Gur G, Kul K, Guclu M, Boyacioglu S. Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy. World J Gastroenterol 2005 11 : 2764 7.
38. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori Infection With Systemic Inflammation and Endothelial Dysfunction in Healthy Male Subjects. J Am Coll Cardiol 2005 45 : 1219 22.
39. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992 268 : 877 81.
40. Ubbink J, Vermaak W, Van der Merwe A, Becker P. Vitamin B12 vitamin B6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993 57 : 47 53.
41. Tamura A, Fujioka T, Nasu M. Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography. Am J Gastroenterol 2002 97 : 861 6.
42. Serin E, Gümürdülü Y, Ozer B, Kayaselcuk F, Yilmaz U, Kocak R. Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy. Helicobacter 2002 7 : 337 41.
43. Rathbone BJ, Johnson AW, Wyatt JI, Kelleher J, Heatley RV, Losowsky MS. Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci 1989 76 : 237 41.
44. Lucock MD, Priestnall M, Daskalakis I, Schorah CJ, Wild J, Levene MI. Nonenzymatic degradation and salvage of dietary folate: physicochemical factors likely to influence bioavailability. Biochem Molec Med 1995 55 : 43 55.
45. On SL, Hynes S, Wadstrom T. Extragastric Helicobacter species. Helicobacter 2002 7 : 63 7.
46. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomized trials. Indian Heart J 2000 52 : S59 64.
47. Potkin BN, Bartorelli AL, Gessert JM, Neville RF, Almagor Y, Roberts WC, Leon MB. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation, 1990 81 : 1575 85.
48. Gomollon F, Ducons JA, Santolaria S, Lera Omiste I, Guirao R, Ferrero M, Montoro M. Breath test is very reliable for diagnosis of Helicobacter pylori infection in real clinical practice. Digestive Liver Dis 2003 35 : 612 8.
49. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995 10 : 111 3.